Memorial Blood Centers’ workforce and donor base includes diverse individuals of all races, ethnicities, genders, and sexual orientation. We value diversity in our community, donors, and team members, and we work to treat all with fairness, equality, and respect.
On May 11, 2023, the U.S. Food and Drug Administration (FDA) issued final guidance establishing a blood donor screening process based on Individual Donor Assessment.
MBC has strived to build an inclusive environment that embraces diversity for all who engage with our lifesaving mission. For decades, we have strongly advocated for scientifically-based changes to the FDA policies about men who have sex with men (MSM) and support the shift to individual donor assessment to determine eligibility. The FDA has finalized recommendations for establishing a blood donor screening process based on Individual Donor Assessment.
Work has already begun to welcome newly eligible donors, a process that includes adopting the new donor history questionnaire, updating and validating computer systems regulated by the FDA, training staff, updating operational procedures and information systems. MBC expects to be able to welcome eligible donors in mid-November 2023 or sooner.
